PathogenDx
PathogenDx, Inc. (PDx) is a biotechnology company that develops testing kits, automation, and software to detect pathogens in plants, food, and the body. The company's patented multiplexed molecular testing technology, Dynamic Dimensional Detection (https://pathogendx.com/science/) or D3 ArrayTM, can rapidly detect and identify up to 50 pathogens simultaneously, in a single well test, in less than a single shift providing triplicate data per target/analyte for confidence and certainty in results with a simple and easy process. Our technology is equipment agnostic, and our analytics is automated through our cloud-based software. Our mission is to provide testing technology and solutions for the clinical, food, and agricultural testing markets for Better and Health and safety.
Milan Patel
CEO and Co-Founder
Benjamin Katchman, PhD
Vice President of Product Development
Jeff Ryskamp
CFO
_ Roze
Videographer and Motion Graphic Artist
Mark Schwartz
Scientist/FAS
Maggie Thomas
Field Application Specialist
Ihab Botros
Senior R&D Scientist
Frequently Asked Questions about PathogenDx
Who is the CEO of PathogenDx?▼
The current CEO of PathogenDx is Milan Patel, serving as CEO and Co-Founder.
How many employees does PathogenDx have?▼
PathogenDx has approximately 11-50 employees. We have mapped 7 people in their organizational chart.
What industry is PathogenDx in?▼
PathogenDx operates in the Biotechnology Research industry and is headquartered in Scottsdale, Arizona, United States.
What is PathogenDx's funding stage?▼
PathogenDx is at the seed funding stage.
Who are the key executives at PathogenDx?▼
Key executives at PathogenDx include Milan Patel (CEO and Co-Founder), Benjamin Katchman, PhD (Vice President of Product Development), Jeff Ryskamp (CFO).
Where is PathogenDx headquartered?▼
PathogenDx is headquartered in Scottsdale, Arizona, United States.
Data sourced from Crustdata | the API for B2B company & people data. Access org charts, headcount, funding, and growth metrics for 60M+ companies.